Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1986 1
1990 2
1991 3
1992 4
1993 2
1994 5
1995 2
1996 3
1997 1
1998 4
1999 3
2000 5
2001 3
2002 6
2003 2
2004 5
2005 3
2006 4
2007 3
2008 5
2009 8
2010 8
2011 10
2012 4
2013 8
2014 13
2015 7
2016 15
2017 13
2018 19
2019 19
2020 24
2021 25
2022 15
2023 27
2024 22
2025 16

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

272 results

Results by year

Filters applied: . Clear all
Page 1
Empagliflozin in Patients with Chronic Kidney Disease.
The EMPA-KIDNEY Collaborative Group; Herrington WG, Staplin N, Wanner C, Green JB, Hauske SJ, Emberson JR, Preiss D, Judge P, Mayne KJ, Ng SYA, Sammons E, Zhu D, Hill M, Stevens W, Wallendszus K, Brenner S, Cheung AK, Liu ZH, Li J, Hooi LS, Liu W, Kadowaki T, Nangaku M, Levin A, Cherney D, Maggioni AP, Pontremoli R, Deo R, Goto S, Rossello X, Tuttle KR, Steubl D, Petrini M, Massey D, Eilbracht J, Brueckmann M, Landray MJ, Baigent C, Haynes R. The EMPA-KIDNEY Collaborative Group, et al. N Engl J Med. 2023 Jan 12;388(2):117-127. doi: 10.1056/NEJMoa2204233. Epub 2022 Nov 4. N Engl J Med. 2023. PMID: 36331190 Free PMC article. Clinical Trial.
Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease.
EMPA-KIDNEY Collaborative Group; Herrington WG, Staplin N, Agrawal N, Wanner C, Green JB, Hauske SJ, Emberson JR, Preiss D, Judge P, Zhu D, Dayanandan R, Arimoto R, Mayne KJ, Ng SYA, Sammons E, Hill M, Stevens W, Wallendszus K, Brenner S, Cheung AK, Liu ZH, Li J, Hooi LS, Liu W, Kadowaki T, Nangaku M, Levin A, Cherney DZI, Maggioni AP, Pontremoli R, Deo R, Goto S, Rossello X, Tuttle KR, Steubl D, Massey D, Brueckmann M, Landray MJ, Baigent C, Haynes R; EMPA-KIDNEY Collaborative Group. EMPA-KIDNEY Collaborative Group, et al. N Engl J Med. 2025 Feb 20;392(8):777-787. doi: 10.1056/NEJMoa2409183. Epub 2024 Oct 25. N Engl J Med. 2025. PMID: 39453837 Free PMC article. Clinical Trial.
Conservative versus Interventional Treatment for Spontaneous Pneumothorax.
Brown SGA, Ball EL, Perrin K, Asha SE, Braithwaite I, Egerton-Warburton D, Jones PG, Keijzers G, Kinnear FB, Kwan BCH, Lam KV, Lee YCG, Nowitz M, Read CA, Simpson G, Smith JA, Summers QA, Weatherall M, Beasley R; PSP Investigators. Brown SGA, et al. N Engl J Med. 2020 Jan 30;382(5):405-415. doi: 10.1056/NEJMoa1910775. N Engl J Med. 2020. PMID: 31995686 Clinical Trial.
2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients.
Writing Committee Members; Shah MJ, Silka MJ, Silva JNA, Balaji S, Beach CM, Benjamin MN, Berul CI, Cannon B, Cecchin F, Cohen MI, Dalal AS, Dechert BE, Foster A, Gebauer R, Gonzalez Corcia MC, Kannankeril PJ, Karpawich PP, Kim JJ, Krishna MR, Kubuš P, LaPage MJ, Mah DY, Malloy-Walton L, Miyazaki A, Motonaga KS, Niu MC, Olen M, Paul T, Rosenthal E, Saarel EV, Silvetti MS, Stephenson EA, Tan RB, Triedman J, Bergen NHV, Wackel PL. Writing Committee Members, et al. Among authors: mah dy. Heart Rhythm. 2021 Nov;18(11):1888-1924. doi: 10.1016/j.hrthm.2021.07.038. Epub 2021 Jul 29. Heart Rhythm. 2021. PMID: 34363988 Free article.
Let us introduce ourselves, #WeAreBOSEM.
Verhagen E, Oliveira F, Ahmed OH, Anderson N, Badenhorst M, Bekker S, Belavy DL, Blake T, Cao C, Carrard J, Chen L, Cheng SWM, Edouard P, Harwood A, Hendricks S, Hespanhol L, Kearney R, Keohane D, Magnani R, Mah D, Mavros Y, McLeary N, Memon AR, Moholdt T, Morais Azevedo A, Nauta J, Nicol G, Noorbhai H, Ogbonmwan I, Owen PJ, Panagodage Perera N, Reiman M, Resende R, Robinson DG, Rojas-Valverde D, Sewry N, Statuta S, van Nassau F, West L, Wheeler PC, Xiao T, Pandya T. Verhagen E, et al. Among authors: mah d. BMJ Open Sport Exerc Med. 2021 Jun 30;7(2):e001171. doi: 10.1136/bmjsem-2021-001171. eCollection 2021. BMJ Open Sport Exerc Med. 2021. PMID: 34262787 Free PMC article. No abstract available.
Choroideremia gene testing.
MacDonald IM, Sereda C, McTaggart K, Mah D. MacDonald IM, et al. Among authors: mah d. Expert Rev Mol Diagn. 2004 Jul;4(4):478-84. doi: 10.1586/14737159.4.4.478. Expert Rev Mol Diagn. 2004. PMID: 15225095 Review.
Frailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozin from the EMPA-KIDNEY Trial.
Mayne KJ, Sardell RJ, Staplin N, Judge PK, Zhu D, Sammons E, Cherney DZI, Cheung AK, Maggioni AP, Nangaku M, Rossello X, Tuttle KR, Ihara K, Iwata T, Wanner C, Emberson J, Preiss D, Landray MJ, Baigent C, Haynes R, Herrington WG; EMPA-KIDNEY Collaborative Group. Mayne KJ, et al. Clin J Am Soc Nephrol. 2024 Sep 1;19(9):1119-1129. doi: 10.2215/CJN.0000000000000498. Epub 2024 Jun 27. Clin J Am Soc Nephrol. 2024. PMID: 40179340 Clinical Trial.
272 results